Latest News

Immune-modulating drug unexpectedly benefits mice with fatal mitochondrial defect

In a lab devoted to increasing healthy lifespans, the transplant anti-rejection drug rapamycin showed unexpected health benefits and increased survival in a mouse model of a fatal mitochondrial defect. Children with the untreatable condition suffer from brain damage and muscle weakness, and rarely live beyond 6 or 7 years. The drug enables the body to bypass the mitochondrial defect by switching its metabolism to burn fats and amino acids instead of glucose, and thereby reduces toxic byproducts.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Short sleepers are four times more likely to catch a cold

  • Men who buy sex have much in common with sexually coercive men

  • With tobacco, what you don't know can kill you sooner

  • New type of prion may cause, transmit neurodegeneration

  • Medication treatment for opioid use disorders in primary care increases patient access

  • Research in mice shows potential value of antidepressant in some stroke victims

  • Dialect influences Appalachian students' experiences in college

  • We've all got a blind spot, but it can be shrunk

  • Predictor of child vocabulary in early speech

  • Raising pay can reduce smoking rates

  •